2-cyano-Pyrimidine

Pyrimidine-2-cyano is a promising inhibitor of cathepsin K being studied for its potential in treating osteoporosis. This small molecule and its derivatives have been found to have a basic structure that effectively targets cathepsin K, a cysteine protease that is mainly active in osteoclasts. Targeting this enzyme's activity could help prevent the development of osteoporosis and arthritis, which have been linked to elevated cathepsin K activity. Further research is underway to explore the full therapeutic potential of pyrimidine-2-cyano and its derivatives.

＞98%

Store at -20° C

Solid

White to yellow Crystalline Powder

Cathepsin K: IC₅₀ = 170 nM

DMSO

Cathepsin K

2-cyano-Pyrimidine has been identified as a potential treatment for osteoporosis as it acts as a potent inhibitor of cathepsin K, an enzyme highly associated with osteoporosis and arthritis. Inhibition of cathepsin K by 2-cyano-Pyrimidine has been found to have an IC50 value of 170 nM. It should be noted that Cathepsin K is a lysosomal cysteine protease found in osteoclasts. It is believed that the inhibition of cathepsin K could prove to be a promising approach in the development of therapeutics for bone health.